NCT05403710View on ClinicalTrials.gov

Botulinum Toxin Therapy in Hidradenitis Suppurativa

RecruitingOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

June 7, 2022

Primary Completion Date

April 30, 2028

Study Completion Date

April 30, 2028

Conditions
Hidradenitis SuppurativaHyperhidrosis
Interventions
DRUG

Botulinum toxin

Administration of botulinum toxin (50 units/100cm2 injected intradermally) into lesional skin

Trial Locations (1)

01605

RECRUITING

University of Massachusetts Chan Medical School, Worcester

All Listed Sponsors
collaborator

Hidradenitis Suppurativa Foundation

UNKNOWN

collaborator

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH

lead

University of Massachusetts, Worcester

OTHER